Ferring announces European launch of CORTIMENT®MMX® (budesonide) for ulcerative colitis, and new data re-confirms safety and efficacy
Ferring Pharmaceuticals announced today the European launch of CORTIMENT®MMX® (budesonide), the first…
Ferring Pharmaceuticals acquires two phase III ready orthobiologic product candidates from BioSET
Ferring Pharmaceuticals announced today that it has acquired the assets of BioSurface Engineering Technologies, Inc. (BioSET)…
Ferring Pharmaceuticals moves to strengthen growth with appointment of Chief Medical and Chief Scientific officers
Ferring Pharmaceuticals announced today the appointment of Pascal Danglas, MD as Executive Vice President and Chief Medical Officer…
Archives Press release 2015
Archives Press release 2015